China Pharma Holdings (CPHI) Gross Profit Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 36.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.07% |
| Dec 31, 2025 | 52.30% |
| Sep 30, 2025 | 24.34% |
| Jun 30, 2025 | 27.61% |
| Mar 31, 2025 | 7.06% |
| Dec 31, 2024 | -36.30% |
| Sep 30, 2024 | -20.58% |
| Jun 30, 2024 | -153.56% |
| Mar 31, 2024 | -45.23% |
| Dec 31, 2023 | -28.89% |
| Sep 30, 2023 | -90.75% |
| Jun 30, 2023 | -28.62% |
| Mar 31, 2023 | -2.92% |
| Dec 31, 2022 | -47.16% |
| Sep 30, 2022 | -33.32% |
| Jun 30, 2022 | -50.41% |
| Mar 31, 2022 | -31.19% |
| Dec 31, 2021 | 55.60% |
| Sep 30, 2021 | -37.12% |
| Jun 30, 2021 | -50.33% |